CMS Defends “Functional Equivalence”; AWP Proposal Ready, Scully Says

The Centers for Medicare & Medicaid Services is sticking to its position that deeming Amgen's Aranesp "functionally equivalent" to Johnson & Johnson's Procrit is the best approach to handling the product under the Hospital Outpatient Prospective Payment System